Coexisting Allergic Rhinitis In Patients With Moderate-To-Severe Asthma Initiating Dupilumab In Real-World Clinical Practice: The RAPID Registry Study

被引：0

作者：

Peters, Anju ^{[1
]}

Cote, Andreanne ^{[2
]}

Munoz, Xavier ^{[3
]}

Xia, Changming ^{[4
]}

Nash, Scott ^{[4
]}

Hardin, Megan ^{[5
]}

De Prado Gomez, Lucia ^{[6
]}

Sacks, Harry ^{[4
]}

Jacob-Nara, Juby ^{[7
]}

Deniz, Yamo ^{[4
]}

Rowe, Paul ^{[7
]}

Soler, Xavier ^{[4
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA

[2] Laval Univ, Quebec Heart & Lung Inst, Quebec City, PQ, Canada

[3] Servei Pneumol Hosp Vall dHebron, Barcelona, Spain

[4] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[5] Sanofi, Cambridge, MA USA

[6] Sanofi, Madrid, Spain

[7] Sanofi, Bridgewater, NJ USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2024年 / 153卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

290

引用

页码：AB96 / AB96

页数：1

共 50 条

[41] Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan
Hagino, Teppei
Saeki, Hidehisa
Fujimoto, Eita
Kanda, Naoko
JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
[42] Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry
Gall, Rebecca
Jain, Neal
Soong, Weily
Settipane, Russell A.
Xia, Changming
Zhang, Yi
Haselkorn, Tmirah
Jacob-Nara, Juby A.
Siddiqui, Shahid
ADVANCES IN THERAPY, 2023, 40 (03) : 1292 - 1298
[43] Effectiveness of abrocitinib for the treatment of moderate-to-severe atopic dermatitis in patients switched from dupilumab and/or tralokinumab: A real-world retrospective study
Keow, Samantha
Abu-Hilal, Mohannad
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (04) : 734 - 735
[44] Effectiveness and safety of dupilumab in moderate-to-severe atopic dermatitis patients with chronic renal insufficiency: a real-world retrospective study in China
Peng, Cong
Cao, Qiaozhi
Xiong, Feng
Xu, Hui
Li, Jie
MEDCOMM, 2024, 5 (10):
[45] Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting
Ogut, Neslihan Demirel
Yildirim, Sema Koc
Erbagci, Ece
Hapa, Fatma Asli
JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) : 6215 - 6224
[46] Real-world effectiveness and safety of dupilumab in managing children and adolescents with moderate-to-severe atopic dermatitis
Marshall, Claire
Littlewood, Zoe
Herety, Nichola
Heal, Calvin
Sharif, Jennifer
Clayton, Tim
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 196 - 196
[47] Favorable clinical course after discontinuation of omalizumab treatment in patients with allergic severe asthma: A real-world clinical practice
Hamada, Satoshi
Ogino, Eriko
Yasuba, Hirotaka
RESPIRATORY INVESTIGATION, 2024, 62 (05) : 762 - 765
[48] Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience
Stingeni, L.
Bianchi, L.
Antonelli, E.
Caroppo, E. S.
Ferrucci, S. M.
Ortoncelli, M.
Fabbrocini, G.
Nettis, E.
Schena, D.
Napolitano, M.
Gola, M.
Bonzano, L.
Rossi, M.
Fortina, A. Belloni
Balato, A.
Peris, K.
Foti, C.
Guarneri, F.
Romanelli, M.
Patruno, C.
Savoia, P.
Fargnoli, M. C.
Russo, F.
Errichetti, E.
Bianchelli, T.
Bianchi, L.
Pellacani, G.
Feliciani, C.
Offidani, A.
Corazza, M.
Micali, G.
Milanesi, N.
Malara, G.
Chiricozzi, A.
Tramontana, M.
Hansel, K.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (08) : 1292 - 1299
[49] A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis
Napolitano, Maddalena
Fabbrocini, Gabriella
Potestio, Luca
Fontanella, Giuseppina
Picone, Vincenzo
Bennardo, Luigi
Scalvenzi, Massimiliano
Patruno, Cataldo
DERMATOLOGIC THERAPY, 2022, 35 (08)
[50] Real-world clinical efficacy of tofacitinib in moderate-to-severe ulcerative colitis
Lopes, Sara R.
Martins, Claudio
Teixeira, Madalena
Tomas, David
WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (34)

← 1 2 3 4 5 →